Diet Plus 14:10 Fasting Lowered HbA1c in Women with Type 2 Diabetes

Key Takeaways

• In Indian women with type 2 diabetes, a 24-week lacto-vegetarian diet plus 14-hour time-restricted eating was associated with significantly lower HbA1c than usual diabetes care.
• Insulin resistance (HOMA-IR) and lipid measures also improved significantly with the combined approach.
• Body weight, BMI, and glycemic and lipid profiles were all lower (adjusted) in the intervention group compared with usual diabetes care.
• The regimen was generally well tolerated, but the study could not disentangle the roles of the lacto-vegetarian diet, the 14-hour eating window, and any associated changes in energy intake or weight loss.

Sustaining nutrition strategies that fit daily life remains a persistent challenge for women managing type 2 diabetes, especially when work, caregiving, and meal preparation compete with glucose control. In India, a lacto-vegetarian eating pattern paired with a flexible 14-hour daily fasting window offers a culturally familiar option that may be easier to maintain than stricter regimens. Whether that combined approach could be delivered over 24 weeks against usual diabetes care in Indian women was the clinical question behind this trial.

In a multicenter, randomized, open-label, parallel-arm trial in India published in Nutrition & Diabetes, investigators enrolled 96 women, of whom 90 completed the 24-week study. Participants were 25–60 years old with type 2 diabetes. The intervention combined a lacto-vegetarian diet with a 14-hour daily fasting period (time-restricted eating, or TRE), while the comparator was usual diabetes care. The diet was structured to provide 15–20% protein, 20–25% fat, and 50–55% carbohydrate, with improved carbohydrate quality from whole grains and high-fiber foods. Biochemical and anthropometric measurements were taken at baseline and 24 weeks, and the analysis followed an intention-to-treat protocol.

At 24 weeks, baseline-adjusted between-group comparisons showed significantly greater improvements in the intervention group across body weight, BMI, glycemic measures, and lipid profiles. HbA1c was 6.53% in the intervention group versus 7.65% in the control group, an adjusted mean difference of −1.12 percentage points (95% CI −1.35 to −0.89; p<0.001). HOMA-IR, a measure of insulin resistance, was also significantly lower in the intervention group, with an adjusted mean difference of −1.84 (95% CI −2.27 to −1.41; p<0.001).

The regimen was generally well tolerated, with adverse events described as mild and transient. Most participants in the intervention group also reported improved energy, mood, weight loss, and overall health, though these were reported as exploratory, participant-perceived outcomes rather than primary endpoints.

Because the intervention bundled a lacto-vegetarian diet with a 14-hour eating window as a single package, the trial cannot attribute the observed glycemic and metabolic changes to either component individually, or separate them from any associated changes in energy intake or weight loss that may have accompanied the combined regimen. The trial was also open-label, which the authors themselves note as a design limitation for interventions of this kind.

The authors concluded that pairing a lacto-vegetarian pattern with 14-hour TRE was associated with improved metabolic control and insulin sensitivity in this sample of Indian women with type 2 diabetes, describing it as a practical, culturally adaptable, women-centric strategy. They noted that staffing requirements, cost, and scalability would need further evaluation before broader implementation in clinical nutrition services.

Clinician Questions

What was the study population for the lacto-vegetarian plus 14-hour TRE trial in type 2 diabetes?

The trial enrolled 96 women in India, ages 25–60, with type 2 diabetes; 90 completed the 24-week study.

What did the combined dietary intervention involve?

The intervention combined a structured lacto-vegetarian diet — providing 15–20% protein, 20–25% fat, and 50–55% carbohydrate from whole grains and high-fiber foods — with a 14-hour daily fasting window. The comparator group received usual diabetes care.

Why can't the HbA1c and metabolic changes be attributed to time-restricted eating alone?

The intervention bundled a lacto-vegetarian diet with a 14-hour daily fasting period as a single combined regimen, so the trial cannot isolate which element — or whether associated changes in energy intake or weight — drove the observed glycemic and metabolic improvements.

Were any patient-reported benefits described beyond laboratory and weight changes?

Most participants in the intervention group reported improved energy, mood, weight loss, and overall health. These were reported as exploratory, participant-perceived outcomes rather than primary endpoints.